• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Identification of KCTD17 as a RAS stabilizer in hepatocellular carcinoma
Rainbow Wing Hei LEUNG1, Terence Kin Wah LEE1,2
1Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University
2State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University
Correspondence :  Terence Kin Wah LEE ,
Tel: (852) 3400-8799, Fax: (852) 2364-9932, Email: terence.kw.lee@polyu.edu.hk
Received: August 27, 2024   Accepted: August 29, 2024
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 248 View
  • 15 Download
Related articles

Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma

Correspondence on Editorial regarding “KCTD17 as a RAS stabilizer in hepatocellular carcinoma progression”

Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma

Reply to: “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis”

KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1437
TOTAL : 2103036
Close layer